{"schema_version":"secwatch.filing_event.v1","accession":"0001654954-26-005904","form_type":"8-K","ticker":"ZOMDF","cik":"0001684144","company_name":"Zomedica Corp.","filed_at":"2026-06-11T20:15:41+00:00","discovered_at":"2026-06-11T20:17:01.313739+00:00","generated_at":"2026-06-11T20:28:38.963767+00:00","sec_items":["5.07","9.01"],"event_type":"other_material","sentiment":"negative","materiality_score":0.55,"calibrated_materiality_score":0.15,"confidence":"high","headline":"Zomedica shareholders reject advisory vote on executive compensation at 2026 annual meeting","bullets":["Eight director nominees elected; Grant Thornton LLP ratified as auditor for 2026 with 403.3M for.","Say-on-pay proposal failed: 129,290,109 against vs. 99,891,977 for; broker non-votes 200,401,613.","By-law amendment on quorum requirements for adjourned meetings approved: 123,410,315 for, 105,771,772 against.","All director nominees (Rowe, Cohen, Macleod, Nichols, Powers, Whelan, Williams, Heaton) elected with majority support."],"urls":{"canonical":"https://secwatch.observer/filing/0001654954-26-005904","json":"https://secwatch.observer/filing/0001654954-26-005904.json","markdown":"https://secwatch.observer/filing/0001654954-26-005904.md","text":"https://secwatch.observer/filing/0001654954-26-005904.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1684144/000165495426005904/0001654954-26-005904-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1684144/000165495426005904/zom_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-11T20:28:38.963767+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"16892aa360d0d8a9932cf77aea64fd01bda6d532","claim":"Zomedica Corp. shareholders approved Election of eight directors, each for a one-year term at the 2026-06-10 meeting.","evidence_excerpt":"Proposal 1: Election of Eight Directors For Withheld Broker Non-Vote Jeffrey Rowe 148,970,700 80,211,388 200,401,611 Robert Cohen 141,153,095 88,028,993 200,401,611 Chris Macleod 141,041,101 88,140,987 200,401,611 Pam Nichols 146,791,443 82,390,645 200,401,611 Johnny D. Powers 151,457,102 77,724,986 200,401,611 Sean Whelan 141,437,085 87,745,003 200,401,611 Rodney Williams 141,615,934 87,566,154 200,401,611 Larry Heaton 148,997,578 80,184,510 200,401,611","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1684144/000165495426005904/0001654954-26-005904-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"director election"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2026-06-10"}],"fact_type":"shareholder_vote"},{"claim_id":"718a8052a33072231c696d16fef7b8b6e3356cb4","claim":"Zomedica Corp. shareholders approved Ratification of the appointment of Grant Thornton LLP as our independent registered public accounting firm for 2026 at the 2026-06-10 meeting.","evidence_excerpt":"Proposal 2: Ratification of Independent Auditors For: 403,285,558 Withheld: 26,298,141","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1684144/000165495426005904/0001654954-26-005904-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"auditor ratification"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2026-06-10"}],"fact_type":"shareholder_vote"},{"claim_id":"c4a753c48f2c1d6fb44e8b38974f3bb695780b48","claim":"Zomedica Corp. shareholders rejected Advisory vote to approve the compensation of our named executive officers as described in our management information circular and proxy statement for the Annual Meeting at the 2026-06-10 meeting.","evidence_excerpt":"Proposal 3: Advisory Vote on the Company’s Executive Compensation The votes cast on the advisory vote to approve the compensation of our named executive officers disclosed in our management information circular and proxy statement for the Annual Meeting were as follows: For: 99,891,977 Against: 129,290,109 Broker Non-Vote 200,401,613","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1684144/000165495426005904/0001654954-26-005904-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"say on pay"},{"label":"Outcome","value":"failed"},{"label":"Meeting","value":"2026-06-10"}],"fact_type":"shareholder_vote"},{"claim_id":"dba71a2a3236e3111254f66e9573b0ac4d7ebbbd","claim":"Zomedica Corp. shareholders approved Amendment to the By-Laws of the Company to address the quorum requirements for an adjourned meeting of Shareholders at the 2026-06-10 meeting.","evidence_excerpt":"Proposal 4 ; Amendment of the Company’s By-Laws The votes cast to approve an amendment to the By-Laws of the Company to address the quorum requirements for an adjourned meeting of Shareholders as described in the our management information circular and proxy statement for the Annual Meeting were as follows: . For: 123,410,315 Against: 105,771,772 Broker Non-Vote 200,401,613","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1684144/000165495426005904/0001654954-26-005904-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"charter amendment"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2026-06-10"}],"fact_type":"shareholder_vote"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}